2001
Quality of informed consent in cancer clinical trials: a cross-sectional survey
Joffe S, Cook E, Cleary P, Clark J, Weeks J. Quality of informed consent in cancer clinical trials: a cross-sectional survey. The Lancet 2001, 358: 1772-1777. PMID: 11734235, DOI: 10.1016/s0140-6736(01)06805-2.Peer-Reviewed Original ResearchConceptsClinical trialsCancer clinical trialsFuture patientsConsent formCross-sectional surveyNon-standard treatmentAdult patientsInformed consent processTrial participantsIncremental riskProviders' beliefsMultivariate analysisPatientsUncertainty of benefitPatient consentClinical researchStandard questionnaireInformed consentTrialsConsent processTherapeutic misconceptionCancer therapyConsentParticipantsTreatmentQuality of Informed Consent: a New Measure of Understanding Among Research Subjects
Joffe S, Cook E, Cleary P, Clark J, Weeks J. Quality of Informed Consent: a New Measure of Understanding Among Research Subjects. Journal Of The National Cancer Institute 2001, 93: 139-147. PMID: 11208884, DOI: 10.1093/jnci/93.2.139.Peer-Reviewed Original Research
1995
Health-related quality of life in patients with advanced prostate cancer: A multinational perspective
Cleary P, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: A multinational perspective. Quality Of Life Research 1995, 4: 207-220. PMID: 7613531, DOI: 10.1007/bf02260860.Peer-Reviewed Original ResearchConceptsHealth-related qualityAdvanced prostate cancerProstate cancerSelf-administered patient questionnaireUntreated metastatic prostate cancerObjective tumor responseDomains of HRQOLMetastatic prostate cancerAntiandrogen therapyPatient questionnaireStudy entryTreatment failureStudy treatmentTumor responseClinical trialsPatientsCancerTrialsTreatmentQuestionnaireHRQoLAntiandrogensTherapyCastrationFocus of concern
1994
The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis
Cleary P, Morrissey G, Yver A, Oster G. The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis. Quality Of Life Research 1994, 3: 307-315. PMID: 7841964, DOI: 10.1007/bf00451722.Peer-Reviewed Original ResearchConceptsHealth-related qualityGeneral health perceptionStudy patientsCongenital agranulocytosisHealth perceptionMulticentre phase II clinical trialPhase II clinical trialRecombinant human granulocyte colony-stimulating factorRG-CSF therapyAspects of HRQOLInitiation of treatmentGranulocyte colony-stimulating factorHuman granulocyte colony-stimulating factorValue of treatmentColony-stimulating factorPatient populationFunctional statusOne-half monthsSuch therapyClinical trialsActivity limitationsTherapyStudy centersHRQoLAgranulocytosis
1991
Health-Related Quality of Life Among Patients Undergoing Percutaneous Transluminal Coronary Angioplasty
Cleary P, Epstein A, Oster G, Morrissey G, Stason W, Debussey S, Plachetka J, Zimmerman M. Health-Related Quality of Life Among Patients Undergoing Percutaneous Transluminal Coronary Angioplasty. Medical Care 1991, 29: 939-950. PMID: 1921527, DOI: 10.1097/00005650-199110000-00001.Peer-Reviewed Original ResearchMeSH KeywordsActivities of Daily LivingAdultAgedAngioplasty, Balloon, CoronaryBiphenyl CompoundsCoronary DiseaseEvaluation Studies as TopicHealth Status IndicatorsHeptanoic AcidsHumansInterviews as TopicMiddle AgedOutcome Assessment, Health CarePsychometricsQuality of LifeRandomized Controlled Trials as TopicSurveys and QuestionnairesTelephoneUnited StatesConceptsPercutaneous transluminal coronary artery angioplastyPercutaneous transluminal coronary angioplastyCoronary artery angioplastyHealth-related qualityTransluminal coronary angioplastyNew antiplatelet agentsRandomized clinical trialsQuality of lifeArtery angioplastyAntiplatelet agentsCoronary angioplastyPatient questionnaireStudy entryPatient populationSeparate clinical sitesClinical trialsPatientsClinical sitesSexual functioningTelephone administrationHome managementPhysical wellAngioplastyPsychometric propertiesTrials